Xylem (XYL) Tops Q4 EPS by 12c, Provides FY23 Guidance

Xylem (NYSE: XYL) reported Q4 EPS of $0.92, $0.12 better than the analyst estimate of $0.80. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.41 billion.

GUIDANCE:

Xylem sees FY2023 EPS of $3.00-$3.25, versus the consensus of $3.18.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Carpenter Technology (CRS) PT Raised to $705 at JPMorgan: Staying Cautious Into The Print
• Energizer stock trades 37% below intrinsic value